Qualitative-exploratory questionnaire study as a basis for the development and establishment of an outpatient care concept for patients with cancer-related fatigue (CRF)

Qualitative-exploratory questionnaire study as a basis for the development and establishment of an outpatient care concept for patients with cancer-related fatigue (CRF) - AmCaFa

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034448

Enrollment

Registered

2024-06-15

Start date

2024-08-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer-related fatigue

Interventions

Group 1: Qualitative online survey of patients with cancer-related fatigue

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Presence of cancer-related fatigue lasting at least 6 months - with a score of at least 4 and a maximum of 8 points, measured with the nominated analogue scale - Completion of acute therapy for at least 6 months - Willingness to participate in the study and signed consent

Exclusion criteria

Exclusion criteria: Severe physical or psychological comorbidity due to which a patient is unable to participate in the study - Insufficient knowledge of German - severe physical or psychopharmacologically treated psychiatric comorbidities - Pregnancy - Drug abuse and alcoholism - regular use of sedatives or hypnotics - Lack of ability to complete the questionnaire - physical immobility - Lack of informed consent

Design outcomes

Primary

Measure	Time frame
needs for living with CRF	—

Secondary

Measure	Time frame
dealing with CRF	—

Countries

Germany

Contacts

Public ContactBettina;Verena Adler;Boventer

Evang. Kliniken Essen- Mitte, Klinik für Integrative Onkologie & Supportivmedizin;Evang. Kliniken Essen- Mitte, Klinik für Integrative Onkologie & Supportivmedizin

b.adler@kem-med.com;v.boventer@kem-med.com+4920117439061;+4920117439060

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026